Ligand Avinza launch
Executive Summary
Ligand's Avinza price will range from $231 for 100 30 mg capsules to $790 for 100 120 mg capsules, according to Red Book data. Distribution of extended release morphine is expected to begin in May, with availability broadening for 12 to 18 months post-launch. Promotion will commence in late May or early June; Ligand completed the hiring of its 80-rep sales force in April. Avinza was approved by FDA March 20 (1"The Pink Sheet" March 25, p. 23)...
You may also be interested in...
Ligand Avinza Reimbursement Expected By PBMs Covering 150-200 Mil. Lives
Ligand expects to enter agreements for the opioid Avinza with pharmacy benefit managers covering a total of 150 mil. to 200 mil. lives within the next several months, Ligand CEO Dave Robinson said during an Aug. 13 quarterly call
Ligand Avinza Once-Daily Dosing Will Be Core Promo Message For Elan Opioid
Ligand will focus on Avinza once-daily dosing as the opioid's primary marketing message following the March 20 approval of the extended-release morphine drug licensed from Elan
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.